Christine A. Franke - Concepedia

Author

Christine A. Franke

Oregon State University

Also Known As

C A Franke, C Franke, C. A. Franke, C.A. Franke, Catherine A. Franke, Christine A Franke, Christine A. Franke

Publications

976

Citations

H-Index

Concepts

All Affiliations

Oregon State University Siga Technologies (United States)Rockefeller University California Institute of Technology

About

Christine A. Franke is an author at Oregon State University specializing in medicine, virology, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	812
2	Natural Sciences	7	7	266
3	Biochemistry	4	4	134
4	Biomolecular Engineering	3	3	58
5	Engineering	2	2	72

Christine A. Franke

Publications

892

Citations

H-Index

Page 1

	Year	Citations
Neomycin resistance as a dominant selectable marker for selection and isolation of vaccinia virus recombinants. Christine A. Franke, Charles M. Rice, James H. Strauss, Molecular and Cellular Biology Viral ReplicationSynthetic VirologyImmunologyNeo GeneAntibiotic G418	1985	128
Inactivation of the <i>srtA</i> Gene in <i>Streptococcus gordonii</i> Inhibits Cell Wall Anchoring of Surface Proteins and Decreases In Vitro and In Vivo Adhesion Tové C. Bolken, Christine A. Franke, Kevin F. Jones, Infection and Immunity Microbial PathogensSrta Gene ProductMedicineCell AdhesionPathogenesis	2001	106
Expression of Sindbis virus structural proteins via recombinant vaccinia virus: synthesis, processing, and incorporation into mature Sindbis virions Charles M. Rice, Christine A. Franke, James H. Strauss, Journal of Virology Viral ReplicationImmunologyMolecular BiologyViral Structural ProteinVirus Structure	1985	90
Proteolytic maturation of vaccinia virus core proteins: identification of a conserved motif at the N termini of the 4b and 25K virion proteins Judy K. VanSlyke, Christine A. Franke, Dennis E. Hruby Journal of General Virology Viral ReplicationConserved MotifVirion ProteinsMolecular BiologyViral Structural Protein	1991	63
Use of a cell-free system to identify the vaccinia virus L1R gene product as the major late myristylated virion protein M25 Christine A. Franke, Elizabeth M. Wilson, Dennis E. Hruby Journal of Virology Viral ReplicationEngineeringVirion Protein M25ImmunologyMolecular Biology	1990	57
Identification and analysis of three myristylated vaccinia virus late proteins Karen H. Martin, Douglas W. Grosenbach, Christine A. Franke, Journal of Virology VaccinationVirus StructureMolecular VirologyVirus Late ProteinsPathogenesis	1997	54
Neomycin Resistance as a Dominant Selectable Marker for Selection and Isolation of Vaccinia Virus Recombinants Christine A. Franke, Charles M. Rice, James H. Strauss, Molecular and Cellular Biology Viral ReplicationSynthetic VirologyImmunologyNeo GeneAntibiotic G418	1985	47
Clinical and Microbiological Responses of Volunteers to Combined Intranasal and Oral Inoculation with a <i>Streptococcus gordonii</i> Carrier Strain Intended for Future Use as a Group A Streptococcus Vaccine Karen L. Kotloff, Steven S. Wasserman, Kevin F. Jones, Infection and Immunity Microbial PathogensMicrobiological ResponsesImmunologyNasal CongestionBacterial Pathogens	2005	44
Fatty acid acylation of vaccinia virus proteins Christine A. Franke, P L Reynolds, Dennis E. Hruby Journal of Virology Virion CoreViral ReplicationMolecular VirologyBiochemistryFatty Acid Acylation	1989	40
Immunisation of cattle with a recombinant togavirus-vaccinia virus strain Christine A. Franke, Eugene S. Berry, A. W. Smith, Research in Veterinary Science VaccinationVeterinary VaccineVaccine DevelopmentImmunologyVirology	1985	32

Page 1